Foghorn Therapeutics Inc (FHTX) insider trading
Every open-market stock purchase and sale by Foghorn Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Flagship Pioneering Inc. (Insider), $10M, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $2.04 on Oct 21, 2026.
Recent FHTX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | Stuart Duty (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Michael Mendelsohn (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Douglas G. Cole (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Thomas J. Lynch Jr. (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Simba Gill (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Ian F Smith (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | B Lynne Parshall (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Scott Biller (Insider) | Bought (not open market) | $114K |
| Jun 24, 2026 | Neil Gallagher (Insider) | Bought (not open market) | $114K |
| Apr 10, 2026 | Adrian Gottschalk (CEO) | Bought (not open market) | — |
| Apr 9, 2026 | Adrian Gottschalk (CEO) | Bought (not open market) | — |
| Feb 23, 2026 | Ryan D Maynard (CFO) | Bought (not open market) | $2.3M |
| Feb 5, 2026 | Adrian Gottschalk (CEO) | Bought (not open market) | $5.6M |
| Jan 30, 2026 | Steven F. Bellon (C-suite exec) | Bought (not open market) | $1.7M |
| Jan 30, 2026 | Alfonso Quintas Cardama (C-suite exec) | Bought (not open market) | $1.7M |
| Jan 30, 2026 | Michael LaCascia (C-suite exec) | Bought (not open market) | $1.7M |
| Jan 30, 2026 | Carlos Costa (C-suite exec) | Bought (not open market) | $1.3M |
| Jan 30, 2026 | Anna Rivkin (C-suite exec) | Bought (not open market) | $942K |
| Jan 13, 2026 | Flagship Pioneering LLC (Insider) | Bought (not open market) | $22.5M |
| Jan 13, 2026 | Flagship Pioneering LLC (Insider) | Bought (not open market) | $15M |
Who's trading FHTX
- Simba Gill, Insider: other filings, last Jun 24, 2026
- Scott Biller, Insider: other filings, last Jun 24, 2026
- Ian F Smith, Insider: other filings, last Jun 24, 2026
- B Lynne Parshall, Insider: other filings, last Jun 24, 2026
- Douglas G. Cole, Insider: other filings, last Jun 24, 2026
- Michael Mendelsohn, Insider: other filings, last Jun 24, 2026
- Stuart Duty, Insider: other filings, last Jun 24, 2026
- Thomas J. Lynch Jr., Insider: other filings, last Jun 24, 2026
- Neil Gallagher, Insider: other filings, last Jun 24, 2026
- Adrian Gottschalk, CEO: other filings, last Apr 10, 2026
- Ryan D Maynard, CFO: other filings, last Feb 23, 2026
- Steven F. Bellon, C-suite exec: other filings, last Jan 30, 2026
- Michael LaCascia, C-suite exec: other filings, last Jan 30, 2026
- Carlos Costa, C-suite exec: other filings, last Jan 30, 2026
- Anna Rivkin, C-suite exec: other filings, last Jan 30, 2026
Get free alerts when an insider at Foghorn Therapeutics Inc files a new trade →